2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections
申请人:Canales Eda
公开号:US08536187B2
公开(公告)日:2013-09-17
Pyrido(3,2-d)pyrimidine derivatives represented by the structural formula (Ia): wherein, R1, R2 and R3 are defined herein, pharmaceutical acceptable addition salts, stereochemical isomeric forms, N-oxides, solvates and pro-drugs thereof, for use in the treatment of hepatitis C.
Pyrido(3,2-d)pyrimidine 衍生物的结构式(Ia)如下所示:其中,R1、R2和R3的定义见下文,其药学上可接受的加盐物、立体化学异构体形式、N-氧化物、溶剂化物和前药,用于治疗丙型肝炎。